Effect of HCG on Endometrial Preparation in Frozen Embryo Transfer

August 27, 2024 updated by: Omar Ahmed Mohamed Aly Ahmed Nasr, Assiut University

Effect of Intramuscular Injection of Human Chorionic Gonadotropins on Endometrial Preparation for Frozen Embryo Transfer

Intramuscular injection of HCG to prepare endometrium for frozen embryo transfer

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

This study is to compare the effectiveness of intramuscular injections of Human chorionic gonadotropins in preparing the endometrium for frozen embryo transfer compared to the control group who did not receive the injection

Study Type

Observational

Enrollment (Estimated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Assiut, Egypt, 77777
        • Assiut University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

Reproductive age female

Description

Inclusion Criteria:

  1. Infertile women being prepared for frozen embryo transfer (FET) in an ART program

    Exclusion Criteria:

    • (1) Use of preimplantation genetic test.
  2. History of recurrent spontaneous abortion.
  3. Presence of congenital uterine malformations.
  4. Use of sequential embryo transfer.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Women undergoing preparation for Embryo transfer
Group who received intramuscular injection of HCG before embryo transfer
Human chorionic gonadotropins
Women undergoing preparation for Embryo transfer 1
Group who did not receive intramuscular injection of HCG before embryo transfer

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical pregnancy
Time Frame: 2months
Presence of at least one gestational sac inside the uterus 28 days after embryo transfer
2months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 10, 2024

Primary Completion (Estimated)

May 10, 2025

Study Completion (Estimated)

May 10, 2026

Study Registration Dates

First Submitted

August 27, 2024

First Submitted That Met QC Criteria

August 27, 2024

First Posted (Actual)

August 29, 2024

Study Record Updates

Last Update Posted (Actual)

August 29, 2024

Last Update Submitted That Met QC Criteria

August 27, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • Omar Nasr OBGYN

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on IVF

Clinical Trials on hCG

Subscribe